Biopathologic profile of breast cancer core biopsy: is it always a valid method?

被引:34
作者
Cavaliere, A
Sidoni, A
Scheibel, M
Bellezza, G
Brachelente, G
Vitali, R
Bucciarelli, E
机构
[1] Univ Perugia, Inst Pathol Anat & Histol, Div Canc Res, Policlin Monteluce, I-06122 Perugia, Italy
[2] Univ Perugia, Dept Hyg, Perugia, Italy
关键词
breast cancer; core biopsy; estrogen receptor; progesterone receptor; biopathologic profile;
D O I
10.1016/j.canlet.2004.07.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For breast cancer management biopathologic profile and particularly the expression of estrogen receptor (ER) and progesterone receptor (PR) is considered essential. In advanced cases, core biopsy results are the only data available. To evaluate reliability of data, results of ER, PR, MIB1, p53 and c-erbB2 on core biopsy were compared with those on surgical specimens. Results showed a statistically significant concordance for ER and PR in pT1 but not in pT2 tumors, possibly due to breast cancer heterogeneity. MIB1 results were worse with no significant concordance even for pT1 group. There was statistically significant concordance in pT1 and pT2 groups for p53 and c-erbB 2, probably due to the high number of negative cases for these markers. We recommend more core biopsies for larger tumors since core biopsy has a high probability for giving unreliable data in these cases. In conclusion, this study showed that core biopsy has a high probability for not very reliable data in bigger tumors where the results obtained migth be the only data available. A higher number of core biopsy is recommended in those cases. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 25 条
  • [1] Acheson MB, 1997, ARCH SURG-CHICAGO, V132, P815
  • [2] Cavaliere A, 1996, CYTOMETRY, V26, P204, DOI 10.1002/(SICI)1097-0320(19960915)26:3<204::AID-CYTO4>3.0.CO
  • [3] 2-E
  • [4] Computer-assisted immunocytochemical determination of breast cancer steroid receptors. Frozen sections vs paraffin sections
    Cavaliere, A
    Bellezza, G
    Ferri, I
    Vitali, R
    Sidoni, A
    [J]. BREAST, 2001, 10 (06) : 476 - 483
  • [5] Cavaliere A, 1999, CYTOMETRY, V38, P301, DOI 10.1002/(SICI)1097-0320(19991215)38:6<301::AID-CYTO7>3.0.CO
  • [6] 2-T
  • [7] Preoperative assessment of prognostic factors in breast cancer
    Denley, H
    Pinder, SE
    Elston, CW
    Lee, AHS
    Ellis, IO
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (01) : 20 - 24
  • [8] Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas
    DiLoreto, C
    Puglisi, F
    Rimondi, G
    Zuiani, C
    Anania, G
    DellaMea, V
    Beltrami, CA
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) : 1693 - 1700
  • [9] Tumor-related prognostic factors for breast cancer
    Donegan, WL
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (01) : 28 - 51
  • [10] Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966